Health Canada
- Status: approved
Continuation of boosted PI (Continuation of boosted PI) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic is the originator. The local marketing authorisation holder may differ — check the official source linked above.